# A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.

> **NCT06637631** · PHASE2 · RECRUITING · sponsor: **Sanofi** · enrollment: 260 (estimated)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** SAR441566
- **DRUG:** SAR441566 matching Placebo

## Key facts

- **NCT ID:** NCT06637631
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-10
- **Primary completion:** 2027-07-21
- **Final completion:** 2029-05-23
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06637631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06637631, "A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06637631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*